Literature DB >> 19343439

The impact of a high body mass index on laparoscopy assisted gastrectomy for gastric cancer.

Hyuk-Joon Lee1, Hyung-Ho Kim, Min-Chan Kim, Seong-Yeob Ryu, Wook Kim, Kyo-Young Song, Gyu-Seok Cho, Sang-Uk Han, Woo Jin Hyung, Seung-Wan Ryu.   

Abstract

BACKGROUND: Obesity is known to be associated with postoperative morbidity in gastric cancer surgery, but its impact on laparoscopy assisted gastrectomy (LAG) for gastric cancer has rarely been evaluated.
METHODS: The clinical data for 1,485 LAG procedures for gastric cancer in 10 institutions were reviewed. The patients were divided into high body mass index (BMI) (BMI > or = 25 kg/m(2); n = 432) and low BMI (BMI <25 kg/m(2); n = 1,053) groups, and their clinical outcomes were compared.
RESULTS: The mean age and proportion of comorbid patients were higher in the high BMI group than in the low BMI group. Postoperative morbidity and mortality did not differ between the high BMI (15.7% and 0.9%) and low BMI (14% and 0.5%) groups (p = 0.37 and p = 0.29). Only the operation time and the number of retrieved lymph nodes were significantly different between the high BMI (242.5 min and 30.4) and low BMI (223.7 min and 32.6) groups (p < 0.001 and p = 0.005), especially for male patients undergoing surgery by surgeons who have performed 40 or fewer LAGs.
CONCLUSIONS: High BMI itself may not increase operative morbidity after LAG for gastric cancer. However, when a surgeon is relatively inexperienced with LAG, a careful approach is required for male patients with a high BMI.

Entities:  

Mesh:

Year:  2009        PMID: 19343439     DOI: 10.1007/s00464-009-0419-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  25 in total

1.  Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501).

Authors:  Toshimasa Tsujinaka; Mitsuru Sasako; Seiichiro Yamamoto; Takeshi Sano; Yukinori Kurokawa; Atsushi Nashimoto; Akira Kurita; Hitoshi Katai; Toshio Shimizu; Hiroshi Furukawa; Satoru Inoue; Masahiro Hiratsuka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura
Journal:  Ann Surg Oncol       Date:  2006-12-05       Impact factor: 5.344

2.  Abdominal shape of gastric cancer patients influences short-term surgical outcomes.

Authors:  Jun Ho Lee; Yong Hae Paik; Jong Seok Lee; Keun Won Ryu; Chan Gyoo Kim; Sook Ryeon Park; Young Woo Kim; Myeong Cherl Kook; Byung-Ho Nam; Jae-Moon Bae
Journal:  Ann Surg Oncol       Date:  2007-04       Impact factor: 5.344

Review 3.  Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer.

Authors:  Min-Chan Kim; Ki-Han Kim; Hyung-Ho Kim; Ghap-Joong Jung
Journal:  J Surg Oncol       Date:  2005-07-01       Impact factor: 3.454

4.  Central obesity and coronary heart disease in men.

Authors:  R P Donahue; R D Abbott; E Bloom; D M Reed; K Yano
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

5.  A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan.

Authors:  Seigo Kitano; Norio Shiraishi; Ichiro Uyama; Kenichi Sugihara; Nobuhiko Tanigawa
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

6.  Predictors of operative morbidity and mortality in gastric cancer surgery.

Authors:  D J Park; H-J Lee; H-H Kim; H-K Yang; K U Lee; K J Choe
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

7.  Body-mass index and mortality in Korean men and women.

Authors:  Sun Ha Jee; Jae Woong Sull; Jungyong Park; Sang-Yi Lee; Heechoul Ohrr; Eliseo Guallar; Jonathan M Samet
Journal:  N Engl J Med       Date:  2006-08-22       Impact factor: 91.245

8.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

9.  Laparoscopy-assisted distal gastrectomy for early gastric cancer: is it beneficial for patients of heavier weight?

Authors:  Hirokazu Noshiro; Shuji Shimizu; Eishi Nagai; Kenoki Ohuchida; Masao Tanaka
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

10.  Laparoscopy: the preferred method of cholecystectomy in the morbidly obese.

Authors:  R H Miles; R E Carballo; R A Prinz; M McMahon; G Pulawski; R N Olen; D L Dahlinghaus
Journal:  Surgery       Date:  1992-10       Impact factor: 3.982

View more
  40 in total

1.  A totally laparoscopic distal gastrectomy with gastroduodenostomy (TLDG) for improvement of the early surgical outcomes in high BMI patients.

Authors:  Min Gyu Kim; Hironori Kawada; Beom Su Kim; Tae Hwan Kim; Kap Choong Kim; Jeong Hwan Yook; Byung Sik Kim
Journal:  Surg Endosc       Date:  2010-09-11       Impact factor: 4.584

2.  A totally laparoscopic distal gastrectomy can be an effective way of performing laparoscopic gastrectomy in obese patients (body mass index≥30).

Authors:  Min Gyu Kim; Kap Choong Kim; Beom Su Kim; Tae Hwan Kim; Hee Sung Kim; Jeong Hwan Yook; Byung Sik Kim
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

3.  Lymph Node Noncompliance Affects the Long-Term Prognosis of Patients with Gastric Cancer after Laparoscopic Total Gastrectomy.

Authors:  Guang-Tan Lin; Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Chang-Ming Huang
Journal:  J Gastrointest Surg       Date:  2019-04-01       Impact factor: 3.452

4.  Short-term outcome of total laparoscopic distal gastrectomy for overweight and obese patients with gastric cancer.

Authors:  Motokazu Sugimoto; Takahiro Kinoshita; Hidehito Shibasaki; Yuichiro Kato; Naoto Gotohda; Shinichiro Takahashi; Masaru Konishi
Journal:  Surg Endosc       Date:  2013-06-21       Impact factor: 4.584

Review 5.  Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis.

Authors:  Xiang-Song Wu; Wen-Guang Wu; Mao-Lan Li; Jia-Hua Yang; Qi-Chen Ding; Lin Zhang; Jia-Sheng Mu; Jun Gu; Ping Dong; Jian-Hua Lu; Ying-Bin Liu
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

6.  Laparoscopic versus open appendectomy for the obese patient: a subset analysis from a prospective, randomized, double-blind study.

Authors:  Tatyan Clarke; Namir Katkhouda; Rodney J Mason; Bon C Cheng; Jaisa Olasky; Helen J Sohn; Ashkan Moazzez; Jeffrey Algra; Eric Chaghouri; Thomas V Berne
Journal:  Surg Endosc       Date:  2010-10-29       Impact factor: 4.584

7.  Is laparoscopic gastrectomy safe for western patients with gastric cancer with high body mass index?

Authors:  D Kanellos; I Kanellos
Journal:  Surg Endosc       Date:  2009-09-16       Impact factor: 4.584

8.  Visceral fat area is superior to body mass index as a predictive factor for risk with laparoscopy-assisted gastrectomy for gastric cancer.

Authors:  Kozo Yoshikawa; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Masanori Nishioka; Shinya Morimoto; Tomohiko Miyatani; Masato Komatsu; Chie Mikami; Hideya Kashihara
Journal:  Surg Endosc       Date:  2011-06-18       Impact factor: 4.584

Review 9.  Minimally invasive surgery for gastric cancer: the future standard of care.

Authors:  Keisuke Koeda; Satoshi Nishizuka; Go Wakabayashi
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

10.  Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy.

Authors:  Juhan Lee; Yoo-Min Kim; Yanghee Woo; Kazutaka Obama; Sung Hoon Noh; Woo Jin Hyung
Journal:  Surg Endosc       Date:  2015-01-29       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.